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Primary Immune Deficienes (PID) are a heterogeneous group of inherited disorders in 
which immune system dysfunctions cause an enhanced susceptibility to infections that is 
the common clinical feature of these diseases. To date, more than 200 genes have been 
identified and associated with as many different immunodeficiencies. The frequency of 
PIDs is higher in North-Africa and Middle-East as compared to Europe and North-
America. Indeed, our population is characterized by a high frequency of consanguineous 
marriages which may reach 50% in rural areas. This may account for the higher 
incidence of autosomal recessive immunodeficiencies observed. 
 
During the last twenty years, we’ve diagnosed and investigated at the Institut Pasteur de 
Tunis, a resource-limited institution, 655 tunisian cases of PIDs including patients with 
combined immunodeficiencies, antibody deficiencies, phagocytosis defects, complement 
deficiencies and other well-defined immunodeficiencies.  
 
Our series is characterized by a high incidence of autosomal recessive diseases 
including Ataxia-telangiectasia, Bare Lymphocyte Syndrome, Mendelien Susceptibility to 
Mycobacterial Disease and Leukocyte Adhesion Deficiency. Moreover, we’ve observed 
a high frequency of autosomal recessive forms of classically X-linked 
immunodeficiencies such as Severe Combined Immunodeficiencies, 
Agammaglobulinemia, HyperIgM Syndrome and Chronic Granulomatous Disease. The 
immuno-genetic investigations and the establishment of an accurate diagnosis allowed 
an appropiate and targeted treatment of the affected children e.g. bone marrow 
transplantation, substitutive intravenous immunoglobulins, IFNg or GM-CSF therapy. 
This did also allow us establish a preventive approach by genetic counseling and 
prenatal diagnosis. Moreover, we did contribute to dissection of the IFNg-IL12/23 
dependant pathway in patients with mendelian susceptibility to mycobacterial diseases, 
which might be a model to better understand immune responses during tuberculosis. We 
did also contribute to the World Health Organization efforts to eradicate poliomyelitis by 
studying PIDs patients who can be directly or indirectly infected by oral vaccine strains 
and may become chronic excretors of polioviruses. This is a major concern since long-
lasting strains in the intestine of these patients have been shown to be able to revert and 
cause vaccine-derived poliomyelitis outbreaks, representing a potential reservoir for 
infection in the post eradication era. Furthermore, we contributed to better understand 
the role of TH17 cells in susceptibility to severe fungal diseases and we discovered, 
recently, a novel gene underlying susceptibility to staphylococcal infection, inflammation 
and allergy in hyper-IgE syndrome patients. 
 
In conclusion, the study of these diseases helps establishing accurate diagnosis and 
appropriate treatment of patients. It also contributes unraveling specific immunological 
pathways, in our settings rare autosomal forms offer a privileged physiopathological 
model for infections including some which are linked to global health challenges. 
 
